Market News & Trends
Unilife Enters Definitive Global Strategic Agreement With AbbVie
On January 15, 2015, Unilife Corporation (Unilife) entered into a definitive global strategic agreement with AbbVie Inc. (AbbVie) for the customization and supply of its…
Orphan Drug Prices Facing Increased Scrutiny Following Historic Year for Approvals
With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set…
Depomed to Acquire US Drug Franchise Rights $1.05 Billion
Depomed, Inc. recently announced it has entered into a definitive agreement to acquire the US rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for…
CTI BioPharma Raises $112 Million for New Biotech Fund
CTI Life Sciences recently announced the first closing of its second venture capital fund (CTI II), with C$134 million of capital now available for investment.…
SGS Expands Biomarker Services
SGS Life Science Services recently announced that its laboratory in Poitiers, France, has successfully completed a full analytical validation of the novel Meso Scale Discovery…
Oxford BioTherapeutics Grants Exclusive License to Boehringer Ingelheim
Oxford BioTherapeutics recently announced that Boehringer Ingelheim has exercised an option to receive exclusive rights to an oncology target from an ongoing discovery collaboration. The…
MRIGlobal Wins $54-Million Contract to Support Drug Development
MRIGlobal recently announced it has been awarded a $54-million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the…
Catalent to Collaborate on SMARTag
Catalent Pharma Solutions recently announced it has entered into a collaboration with Sanofi-Aventis Recherche & Développement, a Sanofi Company (EURONEXT: SAN) (NYSE: SNY) to implement…
Denmark’s Pharmaceutical Market Value to Decline to $3 Billion by 2020
Denmark’s pharmaceutical market will decline in value from $3.5 billion in 2013 to $3 billion by 2020, with price-cap agreements and high tax rates on…
FREE WEBINAR - Analysts Predict a Big Year for Healthcare in 2015!
Find out what lies ahead as Frost & Sullivan’s healthcare futurists offer their bold predictions for the entire healthcare industry WHEN …
goBalto Announces Latest Release of goBalto Activate
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, recently announced the release of its latest version of goBalto Activate, its flagship study startup…
Frost & Sullivan Releases Drug Launch Phase III Trial Watch List for Top Therapeutic Areas
The therapeutics market is buzzing with activity, as several promising therapies are progressing to Phase III clinical trials and many more are awaiting commercial launches.…
Global Cancer Vaccine Market to Reach $4.3 Billion in 2019
BCC Research recently announced in its new report, Cancer Vaccines: Technologies and Global Markets, the global market for cancer vaccines is expected to grow to…
Capsugel Acquires Ionic Liquids Technology
Morristown, N.J., and Melbourne, Australia – Capsugel and Monash University recently announced that Capsugel has acquired the intellectual property pertaining to proprietary Ionic Liquids Technology…
Moderna Launches New Venture for Infectious Diseases
Moderna Therapeutics recently announced the launch of Valera LLC, a new Moderna venture focused exclusively on the advancement of vaccines and therapeutics for the prevention…
Surface Oncology Announces $35-Million Financing to Advance Next-Generation Cancer Immunotherapies
Surface Oncology recently announced it has closed a $35-million Series A investment round led by Atlas Venture, which initially seeded the company in 2014, Fidelity…
Lyophilization Services of New England Receives Approval to Manufacture Commercial Aseptic Product
Lyophilization Services of New England, Inc. (LSNE) recently announced that following an FDA Pre-Approval Inspection (PAI) in November 2014, their Harvey Road manufacturing site has…
Blend Therapeutics Secures $21 Million and Unveils Novel Pentarin Platform
Blend Therapeutics, Inc. recently announced it has secured $21 million in new funding. The new financing includes additional equity investment from a new investor and…
Amgen & Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration
Amgen (NASDAQ:AMGN) and Kite Pharma (NASDAQ:KITE) recently announced the two companies have entered into a strategic research collaboration and license agreement to develop and commercialize…
Incyte & Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies
Incyte Corporation and Agenus Inc. recently announced a global license, development, and commercialization agreement focused on novel immuno-therapeutics using Agenus’ proprietary Retrocyte Display antibody discovery…
